Nexentis Technologies (NXTS) closed at $0.48 on November 5, 2026, down 13.2% from the previous close, on volume of 183,429 shares (30-day average 789,025).
Data as of November 5, 2026.
Nexentis Technologies announces 1-for-5 reverse stock split
Seeking Alpha News (Thu, 5-Nov 9:34 AM ET)
Nexentis Announces Reverse Stock Split
Globe Newswire (Thu, 5-Nov 9:00 AM ET)
Nexentis says MitoCareX hit an AI screening milestone with Boltz, but validation still lies ahead
Market Chameleon (Thu, 29-Oct 7:04 AM ET)
Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz
Globe Newswire (Thu, 29-Oct 7:22 AM ET)
Globe Newswire (Mon, 26-Oct 8:16 AM ET)
Globe Newswire (Mon, 12-Oct 8:07 AM ET)
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
Globe Newswire (Wed, 7-Oct 7:32 AM ET)
Globe Newswire (Thu, 24-Sep 7:50 AM ET)
Globe Newswire (Wed, 23-Sep 7:07 AM ET)
Market Chameleon (Mon, 22-Jun 5:52 AM ET)
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Nexentis Technologies trades on the NASDAQ stock market under the symbol NXTS.
As of November 5, 2026, NXTS stock price declined to $0.48 with 183,429 million shares trading.
NXTS has a beta of 2.12, meaning it tends to be more sensitive to market movements. NXTS has a correlation of 0.06 to the broad based SPY ETF.
NXTS has a market cap of $699,780.00. This is considered a Sub-Micro Cap stock.
NXTS support price is $.50 and resistance is $.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NXTS shares will trade within this expected range on the day.
